<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04534972</url>
  </required_header>
  <id_info>
    <org_study_id>19-2799</org_study_id>
    <nct_id>NCT04534972</nct_id>
  </id_info>
  <brief_title>Strategy to Avoid Excessive Oxygen in Major Burn Patients</brief_title>
  <acronym>SAVE-O2</acronym>
  <official_title>Strategy to Avoid Excessive Oxygen in Major Burn Patients (SAVE-O2)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to determine the effectiveness of a multimodal educational intervention to&#xD;
      reduce supplemental oxygen use in major burn patients. Investigators will also evaluate the&#xD;
      safety and clinical effectiveness of the more targeted use of oxygen therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oxygen therapy has undisputed importance in the care of critically ill patients to prevent&#xD;
      secondary complications related to hypoxia. Although routine, the practice of excessive&#xD;
      over-oxygenation may be harmful. An expert panel was convened and developed the strong&#xD;
      consensus to target normoxia at an oxygen saturation (SpO2) range of 90-96%, an arterial&#xD;
      oxygen (PaO2) range of 60-100 mmHg (when applicable), and a fraction of inspired oxygen&#xD;
      (FiO2) of 21% for mechanically ventilated patients or room air for nonmechanically ventilated&#xD;
      patients.&#xD;
&#xD;
      Specific Aim: The purpose of this study is to determine the effectiveness of a multimodal&#xD;
      educational intervention to reduce supplemental oxygen use in major burn patients.&#xD;
      Investigators will also evaluate the safety and clinical effectiveness of the more targeted&#xD;
      use of oxygen therapy.&#xD;
&#xD;
      Hypotheses: Clinical efforts to through a multimodal educational intervention will:&#xD;
&#xD;
        1. Improve the proportion of time spent within target normoxia thresholds (oxygen&#xD;
           saturation [SpO2] 90-96% and/or arterial oxygen [PaO2] 60-100 mmHg [when applicable])&#xD;
&#xD;
        2. Limiting use of excessive supplemental oxygen&#xD;
&#xD;
        3. Reduce exposure to hyperoxia without a substantive increase in hypoxic episodes or&#xD;
           adverse effects&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">July 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Supplemental Oxygen Free Days (SOFD)</measure>
    <time_frame>up to 28 days</time_frame>
    <description>Number of days alive and not on supplemental oxygen during the index hospitalization (0 days [worst outcome] to 28 days [best outcome])</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital-Free Days to day 90 (HFD90)</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Number of days alive and outside the hospital (0 days [worst outcome] to 90 days [best outcome])</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital Mortality to day 90</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Dichotomous vital status (survived or died) at hospital discharge or day 90, whichever is first</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Mortality to day 90</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Vital status and date of death censored at hospital discharge or day 90, whichever is first</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator Free Days (VFD) to day 28</measure>
    <time_frame>up to 28 days</time_frame>
    <description>Ventilator Free days = Days off ventilator (0 VFD [worst outcome] to 28 VFD [best outcome])</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Room air</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Duration of supplemental oxygen (FiO2 = 0.21 or room air)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Burn Wound Healing</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Wound closure of &gt;90% of the original burn or time to grafting (for non-full thickness wounds)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge Disposition</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Defined as home (return to prior level of care) or facility (e.g., acute rehab, skilled nursing facility)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Supplemental Oxygen Administered</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Total estimated oxygen volume while in the burn until after hospital arrival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Time on Normoxia Protocol Target</measure>
    <time_frame>up to 90 days</time_frame>
    <description>Defined as SpO2 90-96% or receiving no supplemental oxygen (FiO2 0.21 or room air) while in the burn unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Participants Receiving High Levels of Supplemental Oxygen</measure>
    <time_frame>up to 90 days</time_frame>
    <description>FiO2&gt;0.40 or &gt;4 liters per minute for &gt;2 hours while in the burn unit [excludes time in the operating room]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Time Receiving High Levels of Supplemental Oxygen</measure>
    <time_frame>up to 90 days</time_frame>
    <description>FiO2&gt;0.40 or &gt;4 liters per minute while in the burn unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Time Receiving No Supplemental Oxygen</measure>
    <time_frame>up to 90 days</time_frame>
    <description>FiO2 0.21 or room air while in the burn unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Hypoxic Event (SpO2&lt;88%)</measure>
    <time_frame>up to 90 days</time_frame>
    <description>SpO2 saturation below 88% while in the burn unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Hypoxic Events (SpO2&lt;88%)</measure>
    <time_frame>up to 90 days</time_frame>
    <description>SpO2 saturation below 88% while in the burn unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Hyperoxic Event (SpO2&gt;96%)</measure>
    <time_frame>up to 90 days</time_frame>
    <description>SpO2 saturation above 96% while in the burn unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Hyperoxic Event (SpO2&gt;96%)</measure>
    <time_frame>up to 90 days</time_frame>
    <description>SpO2 saturation above 96% while in the burn unit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Critical Illness</condition>
  <condition>Wounds and Injury</condition>
  <condition>Disease Attributes</condition>
  <condition>Pathologic Processes</condition>
  <arm_group>
    <arm_group_label>Pre-Implementation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control (pre-implementation) group will be burn patients admitted to the burn unit in ICU during the site's control period of the stepped-wedge implementation process (up to 22 months).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-Implementation Targeting Normoxia in Burn ICU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The intervention (post-implementation) group will be patients admitted to the burn unit in ICU during the targeting normoxia intervention period of the stepped-wedge design implementation process (up to 19 months).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Targeting Normoxia (SpO2 90-96%; PaO2 60-100 mmHg)</intervention_name>
    <description>Post-implementation of targeted normoxia through oxygen titration for individual patients. Intervention for treatment of hypoxia will follow usual local practice. Interventions for treatment of hyperoxia (SpO2 &gt;96% or PaO2 &gt; 100 mmHg) will involve down titration of FiO2 (or supplemental oxygen for non-mechanically ventilated patients) within a time frame based on local site preferences-typically in increments of no greater than 0.10 until goal oxygenation in the normoxia range is achieved (including room air [no supplemental oxygen] for non-mechanically ventilated patients).</description>
    <arm_group_label>Post-Implementation Targeting Normoxia in Burn ICU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with acute thermal burn injury who meet the criteria for entry into the state&#xD;
             or national burn data repository&#xD;
&#xD;
          -  Admission to burn unit within 24 hours of burn injury&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18 years&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Known pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adit Ginde, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erin Anderson, RN</last_name>
    <phone>720-999-8760</phone>
    <email>ERIN.L.ANDERSON@CUANSCHUTZ.EDU</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adit Ginde, MD, MPH</last_name>
    <phone>720-848-6777</phone>
    <email>ADIT.GINDE@CUANSCHUTZ.EDU</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama-Birmingham Medical Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Army Institute of Surgical Research</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Leverve XM. To cope with oxygen: a long and still tumultuous story for life. Crit Care Med. 2008 Feb;36(2):637-8. doi: 10.1097/CCM.0B013E31816296AD.</citation>
    <PMID>18216624</PMID>
  </reference>
  <reference>
    <citation>Damiani E, Adrario E, Girardis M, Romano R, Pelaia P, Singer M, Donati A. Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis. Crit Care. 2014 Dec 23;18(6):711. doi: 10.1186/s13054-014-0711-x. Review.</citation>
    <PMID>25532567</PMID>
  </reference>
  <reference>
    <citation>Panwar R, Capellier G, Schmutz N, Davies A, Cooper DJ, Bailey M, Baguley D, Pilcher V, Bellomo R. Current oxygenation practice in ventilated patients-an observational cohort study. Anaesth Intensive Care. 2013 Jul;41(4):505-14.</citation>
    <PMID>23808511</PMID>
  </reference>
  <reference>
    <citation>Suzuki S, Eastwood GM, Peck L, Glassford NJ, Bellomo R. Current oxygen management in mechanically ventilated patients: a prospective observational cohort study. J Crit Care. 2013 Oct;28(5):647-54. doi: 10.1016/j.jcrc.2013.03.010. Epub 2013 May 15.</citation>
    <PMID>23683560</PMID>
  </reference>
  <reference>
    <citation>Rachmale S, Li G, Wilson G, Malinchoc M, Gajic O. Practice of excessive F(IO(2)) and effect on pulmonary outcomes in mechanically ventilated patients with acute lung injury. Respir Care. 2012 Nov;57(11):1887-93. doi: 10.4187/respcare.01696. Epub 2012 May 15.</citation>
    <PMID>22613692</PMID>
  </reference>
  <reference>
    <citation>Parke RL, Eastwood GM, McGuinness SP; George Institute for Global Health; Australian and New Zealand Intensive Care Society Clinical Trials Group. Oxygen therapy in non-intubated adult intensive care patients: a point prevalence study. Crit Care Resusc. 2013 Dec;15(4):287-93.</citation>
    <PMID>24289510</PMID>
  </reference>
  <reference>
    <citation>Iscoe S, Beasley R, Fisher JA. Supplementary oxygen for nonhypoxemic patients: O2 much of a good thing? Crit Care. 2011;15(3):305. doi: 10.1186/cc10229. Epub 2011 Jun 30. Review.</citation>
    <PMID>21722334</PMID>
  </reference>
  <reference>
    <citation>Panwar R, Young P, Capellier G. Conservative oxygen therapy in mechanically ventilated patients. Crit Care Med. 2014 Sep;42(9):e630-1. doi: 10.1097/CCM.0000000000000439.</citation>
    <PMID>25126814</PMID>
  </reference>
  <reference>
    <citation>de Graaff AE, Dongelmans DA, Binnekade JM, de Jonge E. Clinicians' response to hyperoxia in ventilated patients in a Dutch ICU depends on the level of FiO2. Intensive Care Med. 2011 Jan;37(1):46-51. doi: 10.1007/s00134-010-2025-z. Epub 2010 Sep 28.</citation>
    <PMID>20878146</PMID>
  </reference>
  <reference>
    <citation>Girardis M, Busani S, Damiani E, Donati A, Rinaldi L, Marudi A, Morelli A, Antonelli M, Singer M. Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial. JAMA. 2016 Oct 18;316(15):1583-1589. doi: 10.1001/jama.2016.11993.</citation>
    <PMID>27706466</PMID>
  </reference>
  <reference>
    <citation>de Jonge E, Peelen L, Keijzers PJ, Joore H, de Lange D, van der Voort PH, Bosman RJ, de Waal RA, Wesselink R, de Keizer NF. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care. 2008;12(6):R156. doi: 10.1186/cc7150. Epub 2008 Dec 10.</citation>
    <PMID>19077208</PMID>
  </reference>
  <reference>
    <citation>Pannu SR. Too Much Oxygen: Hyperoxia and Oxygen Management in Mechanically Ventilated Patients. Semin Respir Crit Care Med. 2016 Feb;37(1):16-22. doi: 10.1055/s-0035-1570359. Epub 2016 Jan 28. Review.</citation>
    <PMID>26820270</PMID>
  </reference>
  <reference>
    <citation>Kallet RH, Branson RD. Should Oxygen Therapy Be Tightly Regulated to Minimize Hyperoxia in Critically Ill Patients? Respir Care. 2016 Jun;61(6):801-17. doi: 10.4187/respcare.04933. Review.</citation>
    <PMID>27235315</PMID>
  </reference>
  <reference>
    <citation>Hafner S, Beloncle F, Koch A, Radermacher P, Asfar P. Hyperoxia in intensive care, emergency, and peri-operative medicine: Dr. Jekyll or Mr. Hyde? A 2015 update. Ann Intensive Care. 2015 Dec;5(1):42. doi: 10.1186/s13613-015-0084-6. Epub 2015 Nov 19.</citation>
    <PMID>26585328</PMID>
  </reference>
  <reference>
    <citation>Singh V, Devgan L, Bhat S, Milner SM. The pathogenesis of burn wound conversion. Ann Plast Surg. 2007 Jul;59(1):109-15. Review.</citation>
    <PMID>17589272</PMID>
  </reference>
  <reference>
    <citation>Cancio LC, Barillo DJ, Kearns RD, Holmes JH 4th, Conlon KM, Matherly AF, Cairns BA, Hickerson WL, Palmieri T. Guidelines for Burn Care Under Austere Conditions: Surgical and Nonsurgical Wound Management. J Burn Care Res. 2017 Jul/Aug;38(4):203-214. doi: 10.1097/BCR.0000000000000368.</citation>
    <PMID>27355660</PMID>
  </reference>
  <reference>
    <citation>Palmieri TL, Przkora R, Meyer WJ 3rd, Carrougher GJ. Measuring burn injury outcomes. Surg Clin North Am. 2014 Aug;94(4):909-16. doi: 10.1016/j.suc.2014.05.010. Review.</citation>
    <PMID>25085096</PMID>
  </reference>
  <reference>
    <citation>Kao Y, Loh EW, Hsu CC, Lin HJ, Huang CC, Chou YY, Lien CC, Tam KW. Fluid Resuscitation in Patients With Severe Burns: A Meta-analysis of Randomized Controlled Trials. Acad Emerg Med. 2018 Mar;25(3):320-329. doi: 10.1111/acem.13333. Epub 2017 Nov 11.</citation>
    <PMID>29024269</PMID>
  </reference>
  <reference>
    <citation>Helmerhorst HJ, Roos-Blom MJ, van Westerloo DJ, de Jonge E. Association Between Arterial Hyperoxia and Outcome in Subsets of Critical Illness: A Systematic Review, Meta-Analysis, and Meta-Regression of Cohort Studies. Crit Care Med. 2015 Jul;43(7):1508-19. doi: 10.1097/CCM.0000000000000998. Review.</citation>
    <PMID>25855899</PMID>
  </reference>
  <reference>
    <citation>Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ. 2010 Oct 18;341:c5462. doi: 10.1136/bmj.c5462.</citation>
    <PMID>20959284</PMID>
  </reference>
  <reference>
    <citation>Chi JH, Knudson MM, Vassar MJ, McCarthy MC, Shapiro MB, Mallet S, Holcroft JJ, Moncrief H, Noble J, Wisner D, Kaups KL, Bennick LD, Manley GT. Prehospital hypoxia affects outcome in patients with traumatic brain injury: a prospective multicenter study. J Trauma. 2006 Nov;61(5):1134-41.</citation>
    <PMID>17099519</PMID>
  </reference>
  <reference>
    <citation>Panwar R, Hardie M, Bellomo R, Barrot L, Eastwood GM, Young PJ, Capellier G, Harrigan PW, Bailey M; CLOSE Study Investigators; ANZICS Clinical Trials Group. Conservative versus Liberal Oxygenation Targets for Mechanically Ventilated Patients. A Pilot Multicenter Randomized Controlled Trial. Am J Respir Crit Care Med. 2016 Jan 1;193(1):43-51. doi: 10.1164/rccm.201505-1019OC.</citation>
    <PMID>26334785</PMID>
  </reference>
  <reference>
    <citation>ICU-ROX Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group, Mackle D, Bellomo R, Bailey M, Beasley R, Deane A, Eastwood G, Finfer S, Freebairn R, King V, Linke N, Litton E, McArthur C, McGuinness S, Panwar R, Young P; ICU-ROX Investigators the Australian and New Zealand Intensive Care Society Clinical Trials Group. Conservative Oxygen Therapy during Mechanical Ventilation in the ICU. N Engl J Med. 2020 Mar 12;382(11):989-998. doi: 10.1056/NEJMoa1903297. Epub 2019 Oct 14.</citation>
    <PMID>31613432</PMID>
  </reference>
  <reference>
    <citation>Schmidt B, Whyte RK, Asztalos EV, Moddemann D, Poets C, Rabi Y, Solimano A, Roberts RS; Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA. 2013 May 22;309(20):2111-20. doi: 10.1001/jama.2013.5555.</citation>
    <PMID>23644995</PMID>
  </reference>
  <reference>
    <citation>Stockinger ZT, Mcswain NE Jr. Prehospital supplemental oxygen in trauma patients: its efficacy and implications for military medical care. Mil Med. 2004 Aug;169(8):609-12.</citation>
    <PMID>15379072</PMID>
  </reference>
  <reference>
    <citation>Meyhoff CS, Wetterslev J, Jorgensen LN, Henneberg SW, Høgdall C, Lundvall L, Svendsen PE, Mollerup H, Lunn TH, Simonsen I, Martinsen KR, Pulawska T, Bundgaard L, Bugge L, Hansen EG, Riber C, Gocht-Jensen P, Walker LR, Bendtsen A, Johansson G, Skovgaard N, Heltø K, Poukinski A, Korshin A, Walli A, Bulut M, Carlsson PS, Rodt SA, Lundbech LB, Rask H, Buch N, Perdawid SK, Reza J, Jensen KV, Carlsen CG, Jensen FS, Rasmussen LS; PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA. 2009 Oct 14;302(14):1543-50. doi: 10.1001/jama.2009.1452.</citation>
    <PMID>19826023</PMID>
  </reference>
  <reference>
    <citation>Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT, Kaye DM; AVOID Investigators. Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction. Circulation. 2015 Jun 16;131(24):2143-50. doi: 10.1161/CIRCULATIONAHA.114.014494. Epub 2015 May 22.</citation>
    <PMID>26002889</PMID>
  </reference>
  <reference>
    <citation>Suzuki S, Eastwood GM, Glassford NJ, Peck L, Young H, Garcia-Alvarez M, Schneider AG, Bellomo R. Conservative oxygen therapy in mechanically ventilated patients: a pilot before-and-after trial. Crit Care Med. 2014 Jun;42(6):1414-22. doi: 10.1097/CCM.0000000000000219.</citation>
    <PMID>24561566</PMID>
  </reference>
  <reference>
    <citation>Eastwood GM, Peck L, Young H, Suzuki S, Garcia M, Bellomo R. Intensive care clinicians' opinion of conservative oxygen therapy (SpO₂ 90-92%) for mechanically ventilated patients. Aust Crit Care. 2014 Aug;27(3):120-5. doi: 10.1016/j.aucc.2013.11.004. Epub 2013 Dec 24.</citation>
    <PMID>24369915</PMID>
  </reference>
  <reference>
    <citation>Helmerhorst HJ, Schultz MJ, van der Voort PH, Bosman RJ, Juffermans NP, de Jonge E, van Westerloo DJ. Self-reported attitudes versus actual practice of oxygen therapy by ICU physicians and nurses. Ann Intensive Care. 2014 Jul 25;4:23. doi: 10.1186/s13613-014-0023-y. eCollection 2014.</citation>
    <PMID>25512878</PMID>
  </reference>
  <reference>
    <citation>Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8.</citation>
    <PMID>10793162</PMID>
  </reference>
  <reference>
    <citation>Baker DW, Persell SD. Criteria for waiver of informed consent for quality improvement research. JAMA Intern Med. 2015 Jan;175(1):142-3. doi: 10.1001/jamainternmed.2014.6977.</citation>
    <PMID>25560946</PMID>
  </reference>
  <reference>
    <citation>McKinney RE Jr, Beskow LM, Ford DE, Lantos JD, McCall J, Patrick-Lake B, Pletcher MJ, Rath B, Schmidt H, Weinfurt K. Use of altered informed consent in pragmatic clinical research. Clin Trials. 2015 Oct;12(5):494-502. doi: 10.1177/1740774515597688. Epub 2015 Sep 15.</citation>
    <PMID>26374677</PMID>
  </reference>
  <reference>
    <citation>Douin DJ, Schauer SG, Anderson EL, Jones J, DeSanto K, Cunningham CW, Bebarta VS, Ginde AA. Systematic review of oxygenation and clinical outcomes to inform oxygen targets in critically ill trauma patients. J Trauma Acute Care Surg. 2019 Oct;87(4):961-977. doi: 10.1097/TA.0000000000002392.</citation>
    <PMID>31162333</PMID>
  </reference>
  <reference>
    <citation>BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group, Stenson BJ, Tarnow-Mordi WO, Darlow BA, Simes J, Juszczak E, Askie L, Battin M, Bowler U, Broadbent R, Cairns P, Davis PG, Deshpande S, Donoghoe M, Doyle L, Fleck BW, Ghadge A, Hague W, Halliday HL, Hewson M, King A, Kirby A, Marlow N, Meyer M, Morley C, Simmer K, Tin W, Wardle SP, Brocklehurst P. Oxygen saturation and outcomes in preterm infants. N Engl J Med. 2013 May 30;368(22):2094-104. doi: 10.1056/NEJMoa1302298. Epub 2013 May 5.</citation>
    <PMID>23642047</PMID>
  </reference>
  <reference>
    <citation>SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Schibler K, Newman NS, Ambalavanan N, Frantz ID 3rd, Piazza AJ, Sánchez PJ, Morris BH, Laroia N, Phelps DL, Poindexter BB, Cotten CM, Van Meurs KP, Duara S, Narendran V, Sood BG, O'Shea TM, Bell EF, Ehrenkranz RA, Watterberg KL, Higgins RD. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010 May 27;362(21):1959-69. doi: 10.1056/NEJMoa0911781. Epub 2010 May 16.</citation>
    <PMID>20472937</PMID>
  </reference>
  <reference>
    <citation>Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007 Feb;28(2):182-91. Epub 2006 Jul 7. Review.</citation>
    <PMID>16829207</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>August 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2020</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypoxia</keyword>
  <keyword>hyperoxia</keyword>
  <keyword>burn</keyword>
  <keyword>critical illness</keyword>
  <keyword>supplemental oxygen</keyword>
  <keyword>oxygenation</keyword>
  <keyword>SpO2</keyword>
  <keyword>PaO2</keyword>
  <keyword>FiO2</keyword>
  <keyword>normoxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Pathologic Processes</mesh_term>
    <mesh_term>Disease Attributes</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

